Patent – Infringement. The Patents Court considered the claimant company's applications for freezing injunctions to prevent both of the defendant companies from selling a full label generic pregabalin product, thereby infringing the claimant's patent. The court held that, in the circumstances, it was appropriate to grant both injunctions.